Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Completed · Phase 2

Conditions studied: Acute Bacterial Skin and Skin Structure Infections

In brief

The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.

Key facts

Study ID
NCT00949130
Run by
Novexel Inc
People needed
180
Starts
2009-11-01
Expected to finish
2010-03-01
Last updated by the study team
2010-03-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.